Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate

Elevated serum phosphate levels as a consequence of chronic kidney disease (CKD) contribute to the increased cardiovascular risk observed in dialysis patients. Protein restriction and dialysis fail to adequately prevent hyperphosphatemia, and in general treatment with oral phosphate binding agents i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Persy, Veerle P, Behets, Geert J, De Broe, Marc E, D’Haese, Patrick C
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2009
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108761/
https://ncbi.nlm.nih.gov/pubmed/21694915
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares